Xcout Intel
Altesa BioSciences, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Altesa BioSciences, Inc. among biotechnology companies — ranked by similarity to what Altesa BioSciences, Inc. actually does, not by market-cap band.
Subscribe to see Altesa BioSciences, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Altesa BioSciences, Inc.
Altesa BioSciences is a clinical-stage pharmaceutical company headquartered in College Park, Georgia. The company is dedicated to improving the lives of individuals suffering from chronic lung diseases, including conditions such as COPD and asthma.
Altesa BioSciences, Inc. at a glance
Altesa BioSciences, Inc. is a biotechnology company headquartered in United States. It has raised at least $110M across the 2 funding rounds on record. Its most recent funding round, Series B, raised $75M in February 2026. Xcout tracks 24 named people at Altesa BioSciences, Inc., including Brett Haumann (Chief Executive Officer).
Altesa BioSciences, Inc. leadership
- Brett HaumannChief Executive Officer
- John ClericiPresident and Chief Operating Officer
- John M. ClericiPresident and Chief Operating Officer
- Andy DrechslerChief Financial Officer
- Kate Knobil, MDChief Medical Officer
- Moncef SlaouiChair
18 more named people on record for Altesa BioSciences, Inc., with roles, board committees and tenure — see the full roster →
Altesa BioSciences, Inc. funding rounds
At least $110M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $75M | 5 named | |
| Series B | $35M | 5 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Altesa BioSciences, Inc. competitors
Ranked by semantic similarity — how close each company is to Altesa BioSciences, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
Celea Therapeutics is a biopharmaceutical company focused on advancing transformative treatments for serious respiratory diseases.
Similar biotechnology company
AeroRx Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing proprietary nebulized combination therapies for chronic obstructive pulmonary disease (COPD).
Similar biotechnology company
Lisata Therapeutics is a clinical-stage pharmaceutical company headquartered in Basking Ridge, New Jersey, dedicated to developing advanced therapies to improve the treatment of various serious diseases.
Similar biotechnology company
Sunterra Bio is a biopharmaceutical company focused on developing inhaled small-molecule therapies for rare pulmonary diseases. Headquartered in Carlsbad, California, the company advances targeted treatments for respiratory conditions.
Biotech
Bellerophon Therapeutics, Inc. is a clinical-stage biopharmaceutical company that engages in the development of products to address pulmonary hypertension related to interstitial lung disease.
Similar biotechnology company
Aer Therapeutics, Inc. is a biotechnology research company based in North Carolina focused on targeting mucus to improve lung health.
Similar biotechnology company
Aiolos Bio is a biotechnology research company headquartered in San Francisco, California, focused on developing novel treatments for respiratory and asthma conditions. The clinical-stage biopharmaceutical firm was acquired by GSK to strengthen its drug development pipeline.
Similar biotechnology company
RaeSedo Holding, Inc. is a biotechnology company developing a novel class of therapeutics for asthma. The company is creating surfactant protein-A (SP-A) derived peptide therapies designed to reduce inflammation, mucus, and airway constriction for asthma patients.
Similar biotechnology company
Atsena Therapeutics, Inc. is a clinical-stage gene therapy company headquartered in Durham, North Carolina, established in 2019. The firm focuses on developing novel gene therapies to treat debilitating inherited blinding diseases using proprietary vector delivery technologies. Its scientific pipeline aims to address areas of high unmet medical need in ophthalmology.
Similar biotechnology company
Expedition Therapeutics is a clinical-stage biotechnology company headquartered in San Francisco, California, developing novel oral small molecule therapies for serious inflammatory and respiratory diseases.
Biotech
Edesa Biotech, Inc. is a biopharmaceutical firm focused on discovering, developing, and commercializing clinical-stage treatments for inflammatory and immune system disorders where current medical options are inadequate. The company's key pipeline assets include EB05, a monoclonal antibody undergoing a Phase 3 clinical trial for acute respiratory distress syndrome (ARDS) in COVID-19 patients, and EB01, a topical therapy in a Phase 2B clinical study addressing chronic allergic contact dermatitis. Furthermore, Edesa has a licensing collaboration with NovImmune SA to advance monoclonal antibodies specifically designed to target TLR4 and CXCL10. This company was established in 2015 and is based in Markham, Canada.
Similar biotechnology company
Savara Inc. is a biopharmaceutical firm in the clinical development phase, specializing in therapies for uncommon respiratory conditions. Their primary investigational drug, molgramostim, is an inhaled form of granulocyte-macrophage colony-stimulating factor (GM-CSF). This compound is currently undergoing Phase III trials to address autoimmune pulmonary alveolar proteinosis. The company's main operations are situated in Austin, Texas.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Altesa BioSciences, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Altesa BioSciences, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →